TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bionor AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
412
|
410
|
314 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
24
|
26
|
-12 |
| EBITDA |
24
|
26
|
-11 |
| Total assets |
124
|
110
|
116 |
| Current assets |
124
|
110
|
116 |
| Current liabilities |
23
|
25
|
42 |
| Equity capital |
101
|
86
|
63 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.5%
|
78.2%
|
54.3% |
| Turnover per employee |
412
|
410
|
314 |
| Profit as a percentage of turnover |
5.8%
|
6.3%
|
-3.8% |
| Return on assets (ROA) |
19.4%
|
23.6%
|
-10.3% |
| Current ratio |
539.1%
|
440.0%
|
276.2% |
| Return on equity (ROE) |
23.8%
|
30.2%
|
-19.0% |
| Change turnover |
16
|
95
|
-15 |
| Change turnover % |
4%
|
30%
|
-5% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.